Results for: drug+company+genentech

FDA approves new targeted breast cancer drug

Facebook adds University of Calif chief to board

AP IMPACT: Big Pharma cashes in on HGH abuse

More firms weigh IPOs as biotech fever reaches Europe

Shares in Japan's Chugai surge on report of Roche buyout offer

New study aims to rapidly test lung cancer drugs

Pfizer Gets Data on 650,000 as 23andMe Turns Spit Into Sales

Combination therapy shows promise in early breast tumors

Obama to propose US spending to research personalized cures

Cancer drugs give Roche a 2012 profit boost

FDA warns of new fake batch of cancer drug Avastin

Genentech Alzheimer's drug misses goals in studies

Doctors use immune therapy against cervical cancer

Lung cancer screening could cost Medicare billions

Eureka moment for 45-year Australian study

Roche to buy U.S. biotech firm InterMune for $8.3 billion

Google's Calico, AbbVie forge deal against diseases of aging

Google 'anti-aging' group has a website

For Roche CEO, celebrating failure is key to success

Genetic test maker 23andMe launches drug R&D effort

More firms weigh IPOs as biotech fever reaches Europe